tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PHAT Stock Latest News

Phathom clarifies no reduction in lead shareholder’s ownership amid 13D filing
The FlyPhathom clarifies no reduction in lead shareholder’s ownership amid 13D filing
1M ago
PHAT
Phathom Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Phathom Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
2M ago
PHAT
Phathom Pharmaceuticals Reports Strong Q2 Growth
PremiumCompany Announcements
Phathom Pharmaceuticals Reports Strong Q2 Growth
2M ago
PHAT
Phathom Pharmaceuticals: Strong Buy Rating Driven by Robust Revenue Performance and Growth Potential
PremiumRatings
Phathom Pharmaceuticals: Strong Buy Rating Driven by Robust Revenue Performance and Growth Potential
2M ago
PHAT
Phathom Pharmaceuticals reports Q2 EPS (79c), consensus (89c)
PremiumThe Fly
Phathom Pharmaceuticals reports Q2 EPS (79c), consensus (89c)
2M ago
PHAT
Phathom Pharmaceuticals sees 2025 revenue $165M-$175M, consensus $159.4M
PremiumThe FlyPhathom Pharmaceuticals sees 2025 revenue $165M-$175M, consensus $159.4M
2M ago
PHAT
Avidity, Phathom mentioned as potential takeout targets at Needham
Premium
The Fly
Avidity, Phathom mentioned as potential takeout targets at Needham
2M ago
BMY
NVO
Phathom Pharmaceuticals appoints Anne Marie Cook as CLO, corporate secretary
Premium
The Fly
Phathom Pharmaceuticals appoints Anne Marie Cook as CLO, corporate secretary
3M ago
PHAT
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
3M ago
RKT
BLNK
Phathom Pharmaceuticals Gains FDA Exclusivity for VOQUEZNA
PremiumCompany Announcements
Phathom Pharmaceuticals Gains FDA Exclusivity for VOQUEZNA
3M ago
8K
PHAT
Phathom Pharmaceuticals announces FDA correction to Orange Book Listing
PremiumThe Fly
Phathom Pharmaceuticals announces FDA correction to Orange Book Listing
3M ago
PHAT
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
4M ago
RDW
ALMS
Phathom Pharmaceuticals Holds Annual Stockholders Meeting
PremiumCompany AnnouncementsPhathom Pharmaceuticals Holds Annual Stockholders Meeting
4M ago
8K
PHAT
Phathom Pharmaceuticals price target raised to $17 from $12 at Craig-Hallum
Premium
The Fly
Phathom Pharmaceuticals price target raised to $17 from $12 at Craig-Hallum
4M ago
PHAT
Phathom Pharmaceuticals Receives Buy Rating Amidst FDA Approval and Market Optimism for VOQUEZNA
Premium
Ratings
Phathom Pharmaceuticals Receives Buy Rating Amidst FDA Approval and Market Optimism for VOQUEZNA
4M ago
PHAT
Phathom Pharmaceuticals Gains FDA Approval for VOQUEZNA® Exclusivity
PremiumCompany Announcements
Phathom Pharmaceuticals Gains FDA Approval for VOQUEZNA® Exclusivity
4M ago
8K
PHAT
Phathom Pharmaceuticals Gains Momentum with FDA Approval and Market Exclusivity for Voquezna
PremiumRatings
Phathom Pharmaceuticals Gains Momentum with FDA Approval and Market Exclusivity for Voquezna
4M ago
PHAT
Needham sees FDA’s positive CP ruling as best-case outcome for Phathom
PremiumThe Fly
Needham sees FDA’s positive CP ruling as best-case outcome for Phathom
4M ago
PHAT
Phathom Pharmaceuticals price target raised to $29 from $23 at Cantor Fitzgerald
PremiumThe Fly
Phathom Pharmaceuticals price target raised to $29 from $23 at Cantor Fitzgerald
4M ago
PHAT
Stifel expects Phathom to ‘largely recover ground lost’ after FDA grants claim
PremiumThe FlyStifel expects Phathom to ‘largely recover ground lost’ after FDA grants claim
4M ago
PHAT
Phathom says FDA to correct Orange Book for Voquenza exclusivity
Premium
The Fly
Phathom says FDA to correct Orange Book for Voquenza exclusivity
4M ago
PHAT
Phathom jumps 124% to $10.49 after FDA corrects Voquenza exclusivity
Premium
The Fly
Phathom jumps 124% to $10.49 after FDA corrects Voquenza exclusivity
4M ago
PHAT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >